Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Churchill Downs
CHDN
$6.08B
| $46.2M | 0.01% |
474,230
+89,934
| +23% | +$8.17M |
|
1177
Wolverine World Wide
WWW
$1.61B
| $46.2M | 0.01% |
1,477,946
-964,709
| -39% | -$28.1M |
|
1178
Constellium
CSTM
$4.08B
| $46.1M | 0.01% |
3,296,614
-388,715
| -11% | -$4.39M |
|
1179
PUT
GE Aerospace
GE
$396B
| $46M | 0.01% |
855,274
-255,310
| -23% | -$11.4M |
|
|
DAY
1180
DELISTED
Dayforce
DAY
| $46M | 0.01% |
431,940
+254,885
| +144% | +$24.1M |
|
1181
Flex
FLEX
$46.3B
| $46M | 0.01% |
3,393,049
+34,772
| +1% | +$402K |
|
1182
HEICO Corp
HEI
$51.5B
| $45.9M | 0.01% |
346,793
-154,842
| -31% | -$18.9M |
|
|
VNET
1183
VNET Group
VNET
$2.09B
| $45.9M | 0.01% |
1,322,513
+605,296
| +84% | +$15.9M |
|
1184
Albemarle
ALB
$14.2B
| $45.8M | 0.01% |
310,724
+54,795
| +21% | +$6.51M |
|
|
CCXI
1185
DELISTED
ChemoCentryx, Inc.
CCXI
| $45.8M | 0.01% |
739,547
+267,725
| +57% | +$15.3M |
|
1186
CALL
ServiceNow
NOW
$121B
| $45.7M | 0.01% |
415,500
| – | – |
|
|
XEC
1187
DELISTED
CIMAREX ENERGY CO
XEC
| $45.7M | 0.01% |
1,219,384
+18,575
| +2% | +$595K |
|
1188
Delta Air Lines
DAL
$61.8B
| $45.6M | 0.01% |
1,133,182
+115,980
| +11% | +$4.22M |
|
1189
FB Financial Corp
FBK
$3.1B
| $45.5M | 0.01% |
1,310,444
-65,742
| -5% | -$2.07M |
|
1190
Merit Medical Systems
MMSI
$5.19B
| $45.4M | 0.01% |
817,703
+2,719
| +0.3% | +$140K |
|
1191
Universal Display
OLED
$3.93B
| $45M | 0.01% |
195,912
+27,057
| +16% | +$5.78M |
|
1192
CALL
Amgen
AMGN
$219B
| $44.9M | 0.01% |
195,500
-9,100
| -4% | -$2.1M |
|
1193
A.O. Smith
AOS
$8.57B
| $44.9M | 0.01% |
818,607
-44,736
| -5% | -$2.47M |
|
1194
Coeur Mining
CDE
$18B
| $44.8M | 0.01% |
4,332,959
+59,353
| +1% | +$487K |
|
1195
Henry Schein
HSIC
$10.2B
| $44.7M | 0.01% |
668,718
-290,397
| -30% | -$18.7M |
|
1196
CubeSmart
CUBE
$9.48B
| $44.7M | 0.01% |
1,329,487
-568,456
| -30% | -$19M |
|
1197
Incyte
INCY
$24.5B
| $44.6M | 0.01% |
513,288
-788,497
| -61% | -$68.2M |
|
1198
iRhythm Holdings
IRTC
$4.1B
| $44.6M | 0.01% |
188,199
+39,005
| +26% | +$8.89M |
|
1199
PUT
IBM
IBM
$225B
| $44.6M | 0.01% |
370,807
+12,657
| +4% | +$1.46M |
|
|
BLUE
1200
DELISTED
bluebird bio
BLUE
| $44.6M | 0.01% |
79,553
+24,134
| +44% | +$15.3M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 644 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.